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Abstract
Dopaminergic nuclei in the basal ganglia are highly sensitive to damage from oxidative stress, inflammation, and
environmental neurotoxins. Disruption of adenosine triphosphate (ATP)-dependent calcium (Ca2+) transients in astrocytes
may represent an important target of such stressors that contributes to neuronal injury by disrupting critical Ca2+-
dependent trophic functions. We therefore postulated that plasma membrane cation channels might be a common site of
inhibition by structurally distinct cationic neurotoxicants that could modulate ATP-induced Ca2+ signals in astrocytes. To test
this, we examined the capacity of two dopaminergic neurotoxicants to alter ATP-dependent Ca2+ waves and transients in
primary murine striatal astrocytes: MPP+, the active metabolite of 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and
6-hydroxydopamine (6-OHDA). Both compounds acutely decreased ATP-induced Ca2+ transients and waves in astrocytes
and blocked OAG-induced Ca2+ influx at micromolar concentrations, suggesting the transient receptor potential channel,
TRPC3, as an acute target. MPP+ inhibited 1-oleoyl-2-acetyl-sn-glycerol (OAG)-induced Ca2+ transients similarly to the TRPC3
antagonist, pyrazole-3, whereas 6-OHDA only partly suppressed OAG-induced transients. RNAi directed against TRPC3
inhibited the ATP-induced transient as well as entry of extracellular Ca2+, which was augmented by MPP+. Whole-cell patch
clamp experiments in primary astrocytes and TRPC3-overexpressing cells demonstrated that acute application of MPP+
completely blocked OAG-induced TRPC3 currents, whereas 6-OHDA only partially inhibited OAG currents. These findings
indicate that MPP+ and 6-OHDA inhibit ATP-induced Ca2+ signals in astrocytes in part by interfering with purinergic receptor
mediated activation of TRPC3, suggesting a novel pathway in glia that could contribute to neurotoxic injury.
Citation: Streifel KM, Gonzales AL, De Miranda B, Mouneimne R, Earley S, et al. (2014) Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic
Calcium Signaling in Astrocytes. PLoS ONE 9(11): e110996. doi:10.1371/journal.pone.0110996
Editor: Wenhui Hu, Temple University School of Medicine, United States of America
Received May 21, 2014; Accepted September 27, 2014; Published November 3, 2014
Copyright:  2014 Streifel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files.
Funding: Funding provided by National Institutes of Health ,www.nih.gov. (ES021656 to RBT, HL091905 to SE, HL094145 to ALG), Rapid Response Innovation
research grant from the Michael J. Fox Foundation for Parkinson’s Research ,www.michaeljfox.org. (to RBT) and Monfort Excellence Award from the Monfort
Family Foundation (to SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: Ron.Tjalkens@colostate.edu
Introduction
Calcium (Ca2+) signaling modulates diverse physiological
processes in the nervous system including exocytosis of neuro-
transmitters, neuronal long-term potentiation [1,2], the propaga-
tion of intercellular Ca2+ waves in astrocytes that regulate
metabolic and trophic support to neurons, and local regulation
of cerebral blood flow [3,4]. Adverse effects resulting from
dysregulation of Ca2+ signaling in neurons during oxidative and
inflammatory conditions has been extensively described [5] but the
pathophysiological effect of alterations in Ca2+ signaling in
astrocytes is less well understood. However, disruptions in
astrocyte Ca2+ signaling could have serious implications for
neuronal function and survival during states of neurological injury
and disease. Transient increases in intracellular Ca2+ are essential
for astrocytic regulation of neuronal excitability in both the
healthy and diseased brain [6] and could therefore be an
important target of both endogenous and exogenous neurotox-
icants. Astrocytes tonically protect against excitotoxic neuronal
injury not only by removing excess synaptic glutamate but also by
dynamically inhibiting glutamatergic synapses through release of
ATP that is degraded to adenosine and suppresses pre-synaptic
currents via the A1 adenosine receptor [4]. Because astrocytic
regulation of excitatory synapses requires Ca2+-dependent release
of ATP, deprecations in Ca2+ signaling in astrocytes could
predispose regional populations of neurons to excitotoxic injury.
Ca2+ signaling in astrocytes could also be dysregulated during
neuroinflammation, as indicated by recent studies which demon-
strated that ATP release from activated microglia evokes P2Y
purinergic receptor-dependent release of neuroactive compounds
from astrocytes, including ATP, D-serine and glutamate [7].
Because activation of glia is a common pathological feature of
multiple neurodegenerative conditions, alterations in astrocyte
Ca2+ signaling could contribute to neuronal dysfunction following
exposure to oxidative or neurotoxic insults or during conditions of
chronic neuroinflammation.
Extracellular ATP activates purinergic receptors (P2 receptors)
on astrocytes [8] that cause rapid increases in intracellular Ca2+.
PLOS ONE | www.plosone.org 1 November 2014 | Volume 9 | Issue 11 | e110996
P2 receptors are divided into two subfamilies: ionotropic (P2X)
receptors and metabotropic (P2Y) receptors. P2Y receptors are
activated by low physiological ATP concentrations (,10 mM),
whereas P2X receptors are activated by high concentrations of
ATP that are released during pathological events such as ischemia
and oxidative stress [9]. P2Y receptors are G-protein-coupled
receptors (GPCR) that activate phospholipase-C (PLC)-dependent
generation of inositol 1,4,5-triphosphate (IP3) that induces release
of Ca2+ from the endoplasmic reticulum. Additionally, PLC
activation generates diacylglycerol (DAG) that stimulates a more
prolonged influx of extracellular Ca2+, resulting in a biphasic Ca2+
response that causes opening of receptor operated channels
including TRPC3 [10]. However, how these Ca2+ influx pathways
are affected by neurotoxic exposures is not well understood. This is
important because sustained increases in [Ca2+]i are required for
exocytosis of ATP in astrocytes following purinergic stimulation
[4].
A possible target of neurotoxic compounds that could decrease
Ca2+ responses to purinergic signals is the transient receptor
potential (TRP) channel, a family of selective and non-selective
cation channels that are widely expressed in diverse cell types,
including astrocytes [10]. Previous research in smooth muscle cells
demonstrated that TRPC3 channels are associated with ATP-
dependent Ca2+ signaling through activation of P2Y Gq GPCR
receptors that activate the PLC-IP3-DAG pathway [11,12]. DAG
is a direct agonist for canonical TRPC3 channels [13,14] that are
abundant in the basal ganglia of both mouse [15] and human [16].
We therefore postulated that this Ca2+-permeable, non-selective
cation channel is associated with vulnerability to the dopaminergic
neurotoxicants, MPP+, the active metabolite of 1-methyl 4-phenyl
1,2,3,6-tetrahydropyridine (MPTP), and 6-hydroxydopamine (6-
OHDA), an endogenous dopamine oxidation product that is
generated at higher levels during aging. We propose a novel
mechanism in astrocytes in which ATP-induced Ca2+ transients
are acutely suppressed by neurotoxic cationic molecules through
inhibition of purinergic signaling and through blockade of TRPC3
channel function, thereby altering the global amplitude of the
intracellular Ca2+ response. To examine mechanisms by which
these neurotoxicants could dysregulate ATP-induced Ca2+ signal-
ing in astrocytes, we acutely exposed cultured striatal astrocytes to
each compound and determined the effect on ATP- or OAG-
induced Ca2+ transients using real-time fluorescence imaging, as
well as the capacity of each compound to inhibit electrophysiologic
Ca2+ currents in cells over-expressing TRPC3 and in primary
astrocytes. The results of these studies indicated that acute
application of each compound prior to stimulation with ATP or
OAG decreased the amplitude of evoked transients, in addition to
diminishing TRPC3-dependent electrophysiological currents in-
duced by OAG. These data suggest that TRPC3 is a receptor-
operated channel in astrocytes linked to the activation of
metabotropic purinergic receptors and that selected cationic
neurotoxicants suppress Ca2+ transients in astrocytes in part by
inhibiting this pathway, implicating this channel as a target that
may be relevant to neurotoxic injury from structurally diverse
cationic molecules.
Materials and Methods
Materials and reagents
All chemical reagents were from Sigma-Aldrich (St. Louis, MO)
unless otherwise stated. C57BL/6J mice were obtained from
Jackson Laboratories (Bar Harbor, ME). Cell culture media and
fluorescent dyes were obtained from Invitrogen (Carlsbad, CA).
Cell culture
Primary astrocytes were isolated from 1–3 day old C57BL/6J
mice from either cortex or striatum, as previously described
[17,18]. Brains were rapidly dissected, extracted and maintained
in Minimal Essential Media (MEM) supplemented with Earle’s
Salts and L-glutamine (Hyclone, Logan, UT), with 10% Fetal
Bovine Serum and 1% penicillin-streptomycin-neomycin (Invitro-
gen, Carlsbad, CA). Cells were grown at 37uC, 5% CO2 in a
humidified incubator for approximately three weeks until reaching
a mature phenotype. Confluent astrocytes were sub-cultured onto
4-well poly-D-lysine-coated chambered glass slides (Nalgene-
Nunc, Thermo Fisher Scientific, Waltham, MA) and allowed to
grow to approximately 75% confluence. In our laboratory,
cultures consistently yield.98% astrocytes as determined by
immunofluorescence staining for glial fibrillary acidic protein [19].
Ethics Statement
All procedures involving animals were conducted under a
protocol approved by the Animal Care and Use Committee at
Colorado State University (IACUC Protocol No. 12-3646A).
According to the guidelines of the National Institutes of Health,
every effort was made to minimize pain and discomfort and all
terminal procedures for isolation of primary cells were conducted
under deep isofluorane anesthesia.
Calcium Imaging
Astrocytes were grown to approximately 75% confluence on 4-
well chamber slides and incubated with Fluo-4 AM (2 mM)
(Molecular Probes, Life Technologies, Carlsbad, CA) for 15 min-
utes at 37uC prior to imaging. Cells were imaged in media (MEM,
without phenol red or sodium bicarbonate) supplemented with
10 mMHEPES (pH 7.4) at 25uC. Groups of approximately 15–30
contiguous cells per field of view were identified for imaging. Cells
were stimulated with ATP (1 mM) to selectively activate metab-
otropic purinergic receptors, rather than ionotropic receptors [9]
or with 1-oleoyl-2-acetyl-sn-glycerol (OAG; 100 mM), a direct
TRPC channel agonist [13]. Compounds (MPP+, 6-OHDA, or
3,4-dihydroxyphenylacetic acid/DOPAC) were added 30 seconds
prior to each agonist. Images of Fluo-4 fluorescence were collected
every 500 milliseconds for 120 seconds with camera binning set at
464 pixels and an exposure time of 20 milliseconds. Images were
collected on a Zeiss Axiovert 200 M microscope equipped with a
Hammatsu ORCA-ER cooled charge-coupled device camera.
Fluorescent intensity was expressed relative to the baseline image
(F/F0), where F0 is the fluorescence level prior to stimulation.
Datasets were analyzed using Slidebook software (v5.0; Intelligent
Imaging Innovations, Inc., Denver, CO).
Mechanical stimulation of calcium waves
For Ca2+ wave propagation studies, astrocytes were sub-
cultured onto poly-D-lysine coated 30 mm round glass coverslips
and placed in a flow chamber (POCmini, Carl Zeiss, New York,
NY). After a 10 second collection of baseline Fluo-4 intracellular
Ca2+ intensity, wave studies were mechanically-induced with a
5 mm diameter glass micropipet using a micromanipulator, as
described previously [19]. Either MPP+, 6-OHDA or DOPAC
(100 mM) were added 30 seconds prior to stimulation and images
were acquired every 500 milliseconds for 60 seconds. Fluorescent
intensity was expressed relative to the baseline image (F/F0) in all
cells within the wave activation site. Wave amplitude and distance
were determined using Slidebook software (v5.0; Intelligent
Imaging Innovations, Inc., Denver, CO).
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Imaging ATP-induced calcium transients
Astrocytic Ca2+ transients were determined by real-time
fluorescence imaging following stimulation with ATP (1 mM) or
OAG (100 mM) in the presence of the phospholipase C (PLC)
inhibitor, U73122 (10 mM), or its inactive analog, U73433
(10 mM). After a 10 min preincubation period with the inhibitor
or analog, the cells were stimulated with 1 mM ATP or 100 mM
OAG and images of Fluo-4 fluorescence collected every 500
milliseconds for 60 seconds. Fluorescent intensity was expressed
relative to the baseline image (F/F0) in all cells. Pyrazole 3 (Pyr3,
10 mM), a selective extracellular inhibitor of TRPC3, was
incubated with astrocytes for 30 minutes prior to imaging at
37uC. Following incubation with Pyr3, cells were stimulated with
ATP or OAG as described. For experiments without extracellular
Ca2+, Ca2+-free imaging medium supplemented with 2 mM
EGTA (pH 7.4) was used in replacement of imaging medium,
with all other experimental conditions held constant. Luciferase
measurements were made using a 96-well luminescence plate
reader (Molecular Dyanmics, Sunnyale, CA).
Electrophysiology
HEK 293 cells were cultured in Dulbecco’s 16 high glucose
modified Eagle’s medium supplemented with 10% fetal bovine
serum and 0.5% penicillin-streptomycin (Gibco, Grand Island,
NY). Cells were incubated at 37uC with 6% CO2 and sub-cultured
when confluent using 0.25% trypsin-EDTA (Gibco). HEK 293
cells were transfected by electroporation with a plasmid that
encodes TRPC3 channels tagged with yellow fluorescent protein
(TRPC3-YFP)[20]. Transfected cells were plated on 12-mm glass
coverslips and allowed to adhere for ,2–3 h at 37uC. Transfected
cells expressing TRPC3-YFP were identified using fluorescent
microscopy. For patch clamp recordings from isolated astrocytes,
confluent cells were sub-cultured onto glass coverslips in Minimal
Essential Media and allowed to adhere for 2–3 hours at 37uC in
5% CO2 humidified incubator. Currents were recorded using an
AxoPatch 200B amplifier equipped with an Axon CV 203BU
headstage (Molecular Devices). Recording electrodes (1–3 MV)
were pulled, polished, and coated with wax to reduce capacitance.
GV seals were obtained in Mg-PSS. Currents were filtered at
1 kHz, digitized at 40 kHz, and stored for subsequent analysis.
Clampex and Clampfit versions 10.2 (Molecular Devices) were
used for data acquisition and analysis, respectively. All patch-
clamp experiments were performed at 25uC. The extracellular
bathing solution contained (mM) 140 NaCl, 5 CsCl, 0.1 MgCl2,
0.05 CaCl2, 10 Glucose, 10 HEPES (pH 7.4). Pipette solution
contained (mM) 130 CsOH, 110 aspartic acid, 15 CsCl, 1 MgCl2,
3.6 CaCl2, 10 EGTA, 10 HEPES (pH 7.4). The calculated
reversal potentials for monovalent and divalent cations are 0 mV
and 224 mV, respectively. Reversal potentials for monovalent
anions are 1.6 mV for these solutions. Cells were initially voltage
clamped at 0 mV, and voltage ramps from2100 mV to +100 mV
were applied every 4 seconds. After baseline currents were
recorded, OAG (100 mM) or ATP (1 mM) was administered to
activate TRPC3 currents. When the evoked current reached a
steady state MPP+ (100 mM), 6-hydroxydopamine, 6-OHDA
(100 mM), or Pyr3 (10 mM) were administered to examine the
effect of these compounds on OAG- or ATP-induced TRPC3
currents.
Expression of Purinergic receptors and TRP channels
Total RNA from cultured astrocytes were prepared using the
RNeasy Mini Kit (Qiagen, Valencia, CA) with on-column DNase
digestion. RNA was quantified using a Nanodrop system (Thermo
Scientific, Wilmington, DE), with the average yield of RNA from
75–100 ng/mL. Whole brain total RNA was prepared with the
Qiagen RNeasy Mini Kit and used for a positive control. cDNA
was synthesized using reverse transcriptase (BioRad, Hercules,
California) and reverse transcriptase-PCR was conducted. PCR
products were visualized with a 1.5% agarose gel with ethidium
bromide staining on a BioRad Chemidoc XRS imager. Primers
used are listed in Table S1.
TRPC3 knockdown
Primary striatal astrocytes (70% confluency) were transfected for
72 hrs with 25–50 pmol of siRNA oligonucleotides (Ambion/Life
Technologies, Grand Island, NY) using the Transit-X2 reagent
(Mirus Bio, Madison, WI) per the manufacturer’s protocol.
Knockdown was confirmed by reverse transcriptase PCR.
Statistical analysis
Differences between three or more means with one independent
variable was performed using one-way analysis of variance
(ANOVA) followed by the Tukey’s multiple comparison post
hoc test using Prism software (v4.0c, Graphpad Software, Inc., San
Diego, CA). Two-component variant analysis was performed using
two-way ANOVA and Sidak’s multiple comparison test. Com-
parisons of two groups were analyzed using the Student’s t-test.
Results are expressed as the mean 6 SEM from a minimum of 3
independent studies and for all experiments, p,0.05 was
considered significant.
Results
Acute exposure to toxicants inhibits Ca2+ transients in
striatal astrocytes
The propagation of intercellular Ca2+ waves between astrocytes
depends heavily upon release of ATP by SNARE proteins (soluble
N-ethylmaleimide-sensitive-factor attachment protein receptor)
and connexin 43 hemi-channels, which is stimulated by a transient
rise in the intracellular Ca2+ concentration [4,8]. The capacity of
low concentrations of dopaminergic neurotoxicants to inhibit
ATP-induced Ca2+ transients was investigated in Figure 1.
Concentrations of ATP from 10 nM–10 mM selectively activate
P2Y purinergic receptors and caused a dose-dependent rise in
intracellular Ca2+ in primary striatal astrocytes, as determined by
real-time fluorescence microscopy (Figure 1a,b). The initial peak
of Ca2+ release from intracellular stores was followed by a
sustained increase in Ca2+ associated with entry from the
extracellular space. The acute effects of 1-methyl-4-phenylpyr-
idinium ion (MPP+) and 6-hydroxydopamine (6-OHDA) on ATP-
induced Ca2+ transients were determined by adding increasing
concentrations of each neurotoxicant to the medium 30 sec prior
to stimulation with ATP. This was done to test the direct effect of
each cationic neurotoxicant on Ca2+ response independent of
longer term alterations such as changes in gene expression or
channel translocation. Increasing concentrations of MPP+ from
0.01 to 10 mM caused a concentration-dependent decrease in the
maximum amplitude of ATP-induced Ca2+ transients in striatal
astrocytes (Figure 1c,d). Acute application of 6-OHDA, an
endogenous oxidation of product of dopamine that is positively
charged at physiological pH, caused a similar dose-dependent
decrease in intracellular Ca2+ in response to ATP (Figure 1e,f).
Inhibition of ATP-induced intracellular Ca2+ transients by 6-
OHDA was selective, because the dopamine metabolite, 3,4-
dihydroxyphenylacetic acid (DOPAC; 10 mM), had no inhibitory
effect on ATP-induced transients (Figure 1e,f). Expression of all P2
receptors was determined in primary astrocytes (Table S1) by
reverse transcriptase PCR (rtPCR). Both cortical and striatal
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astrocytes expressed all P2X receptor subtypes and all P2Y
receptor subtypes, with the exception of P2Y4 and P2Y13, which
were not detected in cortical astrocytes (Table S1a,b). Expression
of TRPC channels was similarly determined by rtPCR and
indicated that subtypes 1–4 of TRPC channels were expressed in
primary cortical astrocytes (Table S1c).
Acute exposure to MPP+ and 6-OHDA attenuates Ca2+
wave propagation in primary astrocytes
Based upon our previous data that the divalent metal, Mn2+,
acutely inhibits mechanically-induced Ca2+ waves in cultured
striatal astrocytes [21], we postulated that MPP+ and 6-OHDA
might similarly diminish Ca2+ wave activity by targeting mem-
brane cation channels. The data in Figure 2 demonstrate that
mechanical stimulation of a single astrocyte in the center of a
confluent field using a 0.5 mm glass micropipet initiated Ca2+
waves that propagated outward from the stimulated cell for
approximately 500 mm, reaching maximal extent within 60 sec.
The amplitude of the wavefront over time is indicated by the
kymograph images in Figure 2, representing the fluorescence
intensity along the line shown in the image panel at 60 sec
following stimulation. Acute application of either MPP+ or 6-
OHDA (100 mM each) 30 sec prior to stimulation of Ca2+ waves
resulted in a dramatic decrease in the amplitude of the wavefront
throughout the field of astrocytes. Quantification of the maximum
intensity of the intracellular Ca2+ transient at the wavefront in
each group is shown in Figure 2d,e. 100 mM MPP+ was more
effective than 6-OHDA at suppressing mechanically-induced Ca2+
waves in striatal astrocytes, although both compounds resulted in
greater than 50% inhibition of the maximum amplitude of the
wavefront. 100 mM MPP+ and 6-OHDA were equally effective in
diminishing the distance of propagation of Ca2+ waves, whereas
acute administration of 100 mM DOPAC resulted in only a slight
decrease in the extent of wave propagation (Figure 2f,g).
Metabotropic receptors mediate ATP-induced Ca2+
transients from intracellular and extracellular sources
In order to identify the site of inhibition of dopaminergic
toxicants on ATP-induced Ca2+ signaling responses in astrocytes,
we first characterized the relative contribution of intracellular and
extracellular Ca2+ in shaping the amplitude and extent of the
ATP-induced transient. Addition of 1 mM ATP caused a rapid
increase in intracellular Ca2+ in striatal astrocytes (Figure 3a) that
was decreased by the PLC inhibitor U73122 (10 mM). Inhibition
of PLC suppressed the initial peak of Ca2+ release from
intracellular stores following addition of ATP, as well as the
resultant receptor-operated influx of Ca2+ influx from the
extracellular space (Figure 3a,b). An inactive analog of U73122,
U73343 (10 mM), had only a very slight effect on the amplitude of
the ATP-induced Ca2+ transient, whereas the vehicle control
(DMSO) had no inhibitory effect. Stimulation with 1 mM ATP in
Ca2+-free imaging medium reduced the peak amplitude of the
Ca2+ transient but abolished the sustained phase of Ca2+ entry
from the extracellular space (Figure 3c,d). These data indicate that
extracellular Ca2+ is an important component of the intracellular
transient in astrocytes following stimulation of PLC-dependent
purinergic receptors with low concentrations of ATP.
OAG elicits Ca2+ transients in astrocytes independently of
intracellular Ca2+ release
Activation of P2Y receptors by ATP generates both IP3 that
induces release of Ca2+ from intracellular stores, as well as
diacylglycerol (DAG) that can trigger influx of extracellular Ca2+
through plasma membrane TRP channels [12,22]. To determine
the contribution of DAG-dependent Ca2+ entry in astrocytes to the
overall ATP-induced transient, we stimulated astrocytes with the
DAG analog, 1-oleoyl-2-acetyl-sn-glycerol (OAG), a membrane
permeable analog of DAG, that directly activates TRPC 3, 6 and
7 [13] (Figure 4). TRPC3, but not TRPC6 or 7, is expressed in
astrocytes cultured by our methods (Figure 2c), consistent with
other reports indicating that TRPC3 is abundant in glial cells [10].
Addition of OAG (100 mM) to primary astrocytes resulted in an
increase in intracellular Ca2+ that was not prevented by
pretreatment with U73122 (10 mM; Figure 4a,b). Removal of
Ca2+ from the extracellular medium prevented OAG-induced
increases in intracellular Ca2+ (Figure 4c). However, OAG
stimulation was still able to elicit a Ca2+ transient following
depletion of intracellular Ca2+ stores by pretreatment with
thapsigargin (10 mM) and caffeine (5 mM; Figure 4d). Thus,
ATP-dependent activation of P2Y receptors in astrocytes results
in influx of extracellular Ca2+ that contributes to the overall
amplitude and shape of the intracellular transient.
GPCR and TRPC channel Ca2+ responses are decreased by
inhibition of TRPC3 and by dopaminergic neurotoxicants
Because DAG/OAG directly regulates entry of extracellular
Ca2+ following stimulation of astrocytes with physiological
concentrations of ATP, we posited that inhibition of TRP
channels would inhibit both ATP- and OAG-induced Ca2+
transients. This hypothesis was tested by the studies in Figure 5,
which used the TRPC3 inhibitor, Pyr3, to prevent entry of
extracellular Ca2+ [23]. These data demonstrate that intracellular
Ca2+ transients in astrocytes induced by stimulation with ATP
(1 mM) were suppressed, although not completely abolished, by
pretreatment (60 sec) with Pyr3 (10 mM; Figure 5a,b). The
sustained phase of Ca2+ entry was inhibited to a greater extent
by Pyr3 than the initial intracellular transient. Combined exposure
to Pyr3 (10 mM) and MPP+ (10 mM) further reduced ATP-induced
Ca2+ transients, although the initial response to ATP was still
present. Pyr3 completely blocked the intracellular response to
OAG (100 mM). (Figure 5c,d). To determine whether MPP+ and
6-OHDA could interfere purinergic receptor activation by directly
modulating ATP as a biochemical cofactor, we conducted in vitro
assays in which purified luciferase was incubated with ATP and
luciferin in the presence of each neurotoxin or apyrase, which
degrades ATP to adenosine (Figure 5e,f). Neither MPP+ or 6-
OHDA showed any inhibitory effect on ATP-dependent luciferase
activity by 10 min (Figure 5f, p,0.0001), whereas ATP degrada-
tion by apyrase rapidly diminished the luminescence signal.
Knockdown of TRPC3 in primary astrocytes using siRNA
oligonucleotides resulted in attenuation of extracellular Ca2+ entry
but did not affect IP3-dependent transients following stimulation
with ATP (Figure 6). Cells transfected with scrambled control
oligonucleotides responded robustly to ATP with a large initial
Ca2+ transient followed by a delayed plateau phase of extracellular
Ca2+ entry (Figure 6a,b). The initial Ca2+ peak was diminished by
MPP+ but not as severely as the secondary plateau phase of
extracellular Ca2+ entry. Knockdown of TRPC3 (.50%;
Figure 6e) resulted in a significant attenuation of the secondary
extracellular Ca2+ entry but had minimal effect on the IP3-
dependent transient (Figure 6c,d). MPP+ partley inhibited the
initial ATP-induced Ca2+ transient following TRPC RNAi and
further reduced the residual plateau phase of Ca2+ below that
caused by TRPC3 RNAi alone (Figure 6c,d). To determine
whether MPP+ and 6-OHDA had a similar effect on OAG-
dependent Ca2+ signaling in astrocytes, Ca2+ responses to
exogenously applied OAG (100 mM) were measured after 30 sec
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pre-incubation with each compound (Figure 6f,g), similar to
pretreatments conducted with Pyr3 in Figure 5. OAG-induced
Ca2+ transients were significantly attenuated by MPP+ (10 mM)
compared to control (Figure 6f). 6-OHDA (10 mM), in contrast,
diminished but did not completely suppress the OAG-induced
Ca2+ transient, although the time to peak amplitude was delayed
and the sustained phase of the Ca2+ transient was decreased
(Figure 6g). These results suggest that TRPC3 modulates ATP-
dependent Ca2+ signals in astrocytes associated largely with the
sustained phase of Ca2+ entry although TRPC3 inhibitors also
Figure 1. Acute exposure to dopaminergic neurotoxicants inhibits Ca2+ transients in striatal astrocytes. (a,b) Application of 10 nM–
10 mM ATP resulted in Ca2+ transients in striatal astrocytes that persisted for greater than 60 sec. (c,d) Addition of MPP+ to the imaging media at
increasing concentrations acutely suppressed ATP-induced Ca2+ transients. Representative traces of astrocytic responses to 1 mM ATP (black
arrowhead indicates time of ATP addition) in the presence of MPP+ (10 nM–10 mM) indicate dose-dependent suppression of intracellular Ca2+
transients. (e,f) Application of 6-OHDA to the imaging media acutely suppressed ATP-induced Ca2+ transients. Representative traces of the response
to 1 mM ATP in the presence of 6-OHDA (10 nM–10 mM) indicate dose-dependent suppression of intracellular Ca2+ transients, where as the dopamine
metabolite, DOPAC (10 mM), did not affect the amplitude of Ca2+ transients. (a,c,e) Vertical bars denote 1 relative fluorescent unit; horizontal bars
denote 10 sec. n = 3 independent experiments; data collected from 50–60 cells group from 2–3 microscopic fields; *p,0.05 relative to control, ** p,
0.01 relative to control and treated groups.
doi:10.1371/journal.pone.0110996.g001
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modestly attenuate the IP3-dependent release from intracellular
stores.
MPP+ inhibits TRPC3-like currents in astrocytes
To determine whether MPP+-dependent inhibition of Ca2+
signaling correlated to a loss of TRPC3 current, we performed
whole-cell patch clamp electrophysiology experiments to isolate
native TRPC3 current in primary striatal astrocytes. Large
transient outward currents were evoked following the administra-
tion of OAG (100 mM), and were blocked with the TRPC3
inhibitor, Pyr3 (10 mM, Figure 7a–c), supporting the presence of
native TRPC3 currents in isolated astrocytes. Due to a possible
global effect of OAG on counteracting K+ currents, we tested
whether local generation of DAG through P2Y receptors could
specifically activate TRPC3-like currents in astrocytes. Consistent
with Ca2+ imaging experiments, administration of extracellular
ATP generated large inward (and outward) currents that were
blocked by MPP+ (Figure 7d–e).
TRPC3 currents are differently affected by MPP+ and 6-
OHDA
To directly measure the effects of MPP+ and 6-OHDA on
TRPC3 channels, recombinant TRPC3 was expressed in HEK
293 cells and channel currents were examined by electrophysiol-
ogy using the whole-cell patch clamp technique (Figure 8). Using
the overexpression of TRPC3 in HEK293 cells, we can have a
high signal-to-noise ratio to better isolate the currents, directly
activate the channel with OAG independent of K+ channels, and
can examine direct pharmacological effects of MPP+ and 6-
OHDA on TRPC3 channels. Control currents from unstimulated
HEK cells were initially small but large currents were evoked
following the administration of the membrane permeable DAG
analog, OAG (100 mM) (Figure 7a,c). OAG-dependent currents in
TRPC3-expressing HEK cells were blocked by the TRPC3
inhibitor, Pyr3 (10 mM; Figure 8d–f), indicating that the measured
currents originated from TRPC3 channel activity. OAG-induced
TRPC3 currents were also strongly inhibited by administration of
100 mM MPP+ (Figure 7b), whereas 100 mM 6-OHDA only
partially inhibited OAG-induced currents, less than either MPP+
or Pyr3 (Figure 7c,d). These results further implicate TRPC3 as a
target of MPP+-mediated inhibition.
Discussion
Calcium (Ca2+) signaling in astrocytes is essential for modulating
diverse physiological processes in the CNS, including synaptic
transmission, neurovascular coupling and metabolic activity in
glial cells [4]. Altered purinergic signaling in astrocytes has been
associated with neurodegenerative diseases that affect the basal
Figure 2. Acute exposure to dopaminergic neurotoxicants
attenuates the propagation of intercellular Ca2+ waves in
primary astrocytes. Calcium waves were initiated in confluent
cultures of striatal astrocytes loaded with Fluo-4 AM (2 mM) using a
glass micropipette to stimulate a single astrocyte in the center of the
field (white arrow). Images were collected every 500 msec for 60 sec. (a)
Control wave and kymograph images were generated from the
fluorescence intensity of Fluo-4 along a representative line drawn from
the point of stimulation to the terminus of the Ca2+ wave across across
the field of astrocytes (a, dotted line). Black arrows denote the point of
stimulation. (b) The extent and intensity of Ca2+ waves is sharply
diminished by acute application of 100 mM MPP+. (c) Similarly to MPP+,
100 mM 6-OHDA diminished the extent and intensity of Ca2+ waves with
acute application. (d,e) The mean intensity of intracellular Ca2+
responses in the cells acutely exposed to 100 mM MPP+ and 6-OHDA
are significantly decreased compared to control. The vertical bar in (d)
denotes 1 relative fluorescent unit; the horizontal bar denotes 10 sec.
(f,g) Representative traces of the total distance of the wave front in
control and acutely-treated cells. Quantitative analysis of Ca2+ wave
propagation indicates that 100 mM MPP+ and 6-OHDA decreases the
distance traveled in striatal astrocytes by.50% relative to control,
whereas 100 mM DOPAC does not abolish wave distance like MPP+ and
6-OHDA although significantly decreased from control. n = 3 waves
analyzed per group for each experiment over 3–4 independent
experiments in separate cultures of striatal astrocytes; *p,0.05 relative
to control, ** p,0.01 relative to control and treated groups.
doi:10.1371/journal.pone.0110996.g002
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ganglia, including Parkinson’s disease [24], but mechanisms
underlying pathophysiological changes in Ca2+ signaling during
disease states and neurotoxic stress are not well understood. We
therefore examined whether selected toxicants of the dopaminer-
gic system could alter ATP-dependent puringergic Ca2+ signaling
in astrocytes in part by acutely inhibiting TRPC3 channels, which
could provide insight into novel glial-specific signaling mechanisms
underlying the sensitivity of dopaminergic nuclei to oxidative and
neurotoxic injury. Although these toxins are structurally distinct
and represent endogenous (6-OHDA) and exogenous (MPP+)
insults, they may share a common mechanism of action in their
capacity to acutely disrupt astrocytic Ca2+ responses to purinergic
stimuli that are critical for maintaining neuronal homeostatic and
trophic functions.
Cultured astrocytes express P2X and P2Y purinergic receptors,
as well as numerous canonical TRPC channels, including TRPC3
(Figure S1). Levels of ATP released during CNS injury can reach
1 mM and preferentially activate P2X ionotropic receptors in
astrocytes, whereas physiological ATP levels up to 10 mM activate
P2Y metabotropic receptors [9]. Striatal astrocytes responded to
ATP with robust intracellular Ca2+ transients that were inhibited
by both MPP+ and 6-OHDA at low micromolar concentrations
(Figure 1), characterized by a decrease in the peak amplitude of
the initial transient and a more pronounced suppression of the
sustained phase of the signal associated with entry of Ca2+ from
the extracellular space. This suggests a direct effect on the activity
of channels associated with capacitive or receptor-operated Ca2+
entry following acute exposure to these neurotoxins, although
there may also be a direct effect on GPCR activity of P2Y
receptors. Additionally, it is possible that either the dopamine
transporter or the organic cation transporter (OCT) could
influence certain long term intracellular effects of MPP+ or 6-
OHDA. Although these channels are expressed in astrocytes [25],
the rapid timescale of inhibition and the lack of bidirectional
transport by OCT makes these channels less likely to acute targets
of MPP+ and 6-OHDA [26]. 6-OHDA causes ROS formation
that can inhibit PLC activity in neuronal cells after 24–72 hrs of
treatment [27] but the short exposure periods used in the present
studies and the lesser effect of 6-OHDA compared to MPP+ likely
precludes ROS formation as a primary mechanism. Furthermore,
acute addition of DOPAC had no effect on ATP-induced Ca2+
transients (Figure 1e,f), demonstrating that only cationic 6-OHDA
was inhibitory and not the anionic carboxylic acid metabolite of
dopamine. Because other GPCR’s have been linked to receptor-
operated Ca2+ channels [12], we postulated that the observed
acute inhibitory effect of these toxicants could involve direct
alteration of such channels in addition to any direct effects on
purinergic receptors.
Acute application of MPP+ or 6-OHDA to confluent cultures of
primary astrocytes also inhibited intercellular Ca2+ waves
(Figure 2). This demonstrates the inhibitory effects of these
compounds in a system that better models in vivo cell-cell
communication, because Ca2+ waves are highly dependent on
purinergic receptor signaling. P2Y receptors are critical to
propagation of intercellular Ca2+ waves in astrocytes [28] and
both MPP+ and 6-OHDA suppressed the intensity and propaga-
Figure 3. ATP stimulates both metabotropic receptors and entry of extracellular Ca2+ in striatal astrocytes. (a,b) Ca2+ transients were
determined in astrocytes by real-time fluorescence imaging following stimulation with 1 mM ATP in the presence of the phospholipase C inhibitor,
U73122 (10 mM), its inactive analog, U73343 (10 mM), or vehicle control (DMSO). Black arrows denote the time of addition of 1 mM ATP. (c–d) Removal
of extracellular Ca2+ inhibited both the peak amplitude and sustained phase of the Ca2+ transient. The vertical bar (a,c) denotes 1 relative fluorescent
unit; the horizontal bar denotes 10 sec. n = 500–700 cells analyzed per experiment over 2–3 independent experiments in separate cultures of striatal
astrocytes; *p,0.05 relative to control, ** p,0.01 relative to control and treated groups.
doi:10.1371/journal.pone.0110996.g003
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tion distance of mechanically induced waves. This indicates that
these compounds not only inhibit ATP-mediated intracellular
Ca2+ transients following exogenous stimulation of P2Y receptors
but also during paracrine release of ATP from astrocytes during
intercellular calcium wave propagation. It was reported in
astrocyte cultures prepared from optic nerve that ATP concen-
trations at the site of mechanical stimulation with a micropipet can
reach 78 mM but that concentrations of ATP released only 100
micrometers distant from the stimulated cell are approximately
7 mM [29], which would therefore selectively activate P2Y in the
majority of cells in the field. We found that the intensity of the
Ca2+ wave 75 micrometers from site of activation was decreased
by both MPP+ and 6-OHDA, relative to control waves (kymo-
graph images in Figure 2a–c), suggesting that P2Y-dependent
Ca2+ responses induced by cell-cell communication between
astrocytes are acutely inhibited by these compounds, similar to
the effect observed on ATP-induced transients. Intracellular Ca2+
transients induced by direct application of ATP were inhibited by
MPP+ and 6-OHDA at lower concentrations than those required
to suppress intercellular waves, likely due to the involvement of
transmitters in addition to ATP that mediate Ca2+ transients
during wave propagation. Astrocytic Ca2+ waves are known to
involve the release of transmitters in addition to ATP, such as
glutamate, that augment wave activity [4] and possibly mobilize
Figure 4. OAG activates Ca2+ transients in astrocytes independently of the phospholipase C - IP3 pathway that require extracellular
Ca2+ but do not require Ca2+ release from intracellular stores. (a,b) Ca2+ transients were stimulated with 100 mM OAG in the presence or
absence of the PLC inhibitor, U73122 (10 mM), or DMSO vehicle control. Quantification of peak amplitudes from (a) indicates that 10 mM U73122 had
no inhibitory effect on OAG-induced Ca2+ transients, suggesting that OAG causes Ca2+ entry separate from the PLC-IP3 pathway. The vertical bar in (a)
denotes 1 relative fluorescent unit; the horizontal bar denotes 10 sec. Black arrows denote the point of stimulation by 100 mM OAG. (c) Ca2+
transients were initiated with 100 mM OAG in the presence or absence of extracellular Ca2+, demonstrating a significant inhibition in OAG response
with the removal of extracellular Ca2+. (d) Intracellular Ca2+ stores were depleted by successive additions of 10 mM thapsigargin and 5 mM caffeine
prior to OAG-induced Ca2+ transients in order to determine the role of intracellular and extracellular Ca2+. Results indicate that prior depletion of
intracellular Ca2+ stores had no effect on OAG-induced Ca2+ transients yet depletion of extracellular Ca2+ inhibited the amplitude of OAG-induced
transients similar to (c). n = 500–700 cells for each experiment over 2–3 independent experiments in separate cultures of striatal astrocytes; *p,0.05.
doi:10.1371/journal.pone.0110996.g004
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Figure 5. Inhibition of TRPC3 decreases ATP- and OAG-induced Ca2+ transients in striatal astrocytes. (a,b) Changes in Fluo-4
fluorescence in striatal astrocytes l following stimulation with 1 mM ATP in presence or absence of the TRPC3 inhibitor, pyrazole-3 (Pyr3; 10 mM). Prior
treatment with Pyr3 for 30 minutes at 37uC decreased the Ca2+ response to ATP, whereas only a modest additive effect was observed with Pyr3 in the
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distinct Ca2+ stores from those activated by ATP, potentially
increasing the concentration of cationic neurotoxin required to
inhibit wave activity.
To identify possible sites of inhibition of MPP+ and 6-OHDA on
ATP-induced Ca2+ transients in striatal astrocytes, we first
determined the relative contribution of intracellular vs. extracel-
lular Ca2+ to the overall amplitude of the transient following
stimulation with ATP. The PLC inhibitor, U73122, significantly
decreased the maximum amplitude of ATP-induced intracellular
Ca2+ transients following stimulation with 1 mM ATP (Figur-
e 3a,b), indicating a requirement for GPCR-dependent activation
of the PLC-IP3 pathway in ATP-induced purinergic signaling.
However, there was still a small residual ATP-induced transient in
the presence of U73122, consistent with previous studies
demonstrating that blockade of PLC signaling in astrocytes with
either 2-APB (2-aminoethyl diphenylborinate) or PMA (phorbol
myristate acetate) was unable to completely abolish ATP-induced
Ca2+ responses [10]. Removal of extracellular Ca2+ only partially
decreased the amplitude of the initial ATP-induced transient but
completely abolished the sustained phase of the Ca2+ response
associated with entry of extracellular Ca2+ (Figure 3c,d), indicating
that Ca2+ from the extracellular space is important in shaping the
amplitude and duration of the intracellular transient following
stimulation with ATP. To further examine the potential site of
inhibition of Ca2+ influx, we used the membrane-permeable
analog of DAG, 1-oleoyl-2-acetyl-sn-glycerol (OAG), which
directly activates TRPC3 channels [13]. Previous studies indicated
that TRPC3 is expressed in astrocytes [30] and we also identified
mRNA for TRPC3 and several other TRP family members in
striatal astrocytes (Figure S1, Table S1), suggesting that this DAG/
OAG-sensitive channel could be an important target of MPP+ and
6-OHDA. Expression of DAG-sensitive TRPC6/7 was not
detected in primary striatal astrocytes, further supporting TRPC3
as the likely site of inhibition of extracellular Ca2+ entry.
OAG directly induced Ca2+ influx in striatal astrocytes
independent of PLC, because U73122 failed to inhibit OAG-
dependent increases in intracellular Ca2+ (Figure 4a,b). Addition-
ally, depletion of extracellular Ca2+ abolished OAG-induced
increases in intracellular Ca2+, whereas prior depletion of
intracellular Ca2+ with caffeine and thapsigargin had no effect
(Figure 4c,d), indicating that OAG directly induces Ca2+ influx
through a plasma membrane cation channel in astrocytes. We
postulated that this channel was TRPC3, because the TRPC3
antagonist, Pyr3, decreased both ATP- and OAG-induced Ca2+
transients in striatal astrocytes (Figure 5), although inhibition of
OAG-induced transients was greater than ATP-induced tran-
sients. Combined treatment with Pyr3 and MPP+ further
diminished the IP3-dependent initial transient induced by ATP
compared to either compound alone but both had a similar
inhibitory effect on the plateau phase of Ca2+ entry, suggesting
that blockade of TRPC3 may have a feedback inhibitory effect
Ca2+-induced Ca2+ release from intracellular stores. The effects of
MPP+ and 6-OHDA on ATP-induced transients was not due to
direct binding and/or interference with the activity of ATP as a
co-factor, because neither compound inhibited luciferase activity
in biochemical assays (Figure 5e,f). In contrast, degradation of
ATP with apyrase resulted in rapid loss of luminescence.
The extent of inhibition of the sustained phase of Ca2+ entry by
Pyr3 during ATP-induced transients suggests that P2Y-dependent
generation of IP3/DAG and subsequent activation of TRPC3
channels following stimulation with ATP is critical to maximal
mobilization of Ca2+ in striatal astrocytes and dramatically
influences the overall amplitude of the intracellular Ca2+ transient.
RNAi knockdown of TRPC3 dramatically attenuated the
sustained phase of Ca2+ entry following the initial IP3-mediated
transient in primary astrocytes, supporting the importance of
TRPC3 to sustained phase of Ca2+ entry (Figure 6a-d, p,0.0001).
The addition of MPP+ to TRPC3 RNAi cells abolished the
residual peak associated with entry of extracellular Ca2+,
supporting that TRPC3 is an important target of MPP+ in
addition to the observed direct effects on purinergic signaling.
Accordingly, acute application of MPP+ attenuated OAG-induced
Ca2+ transients in striatal astrocytes, whereas 6-OHDA was only
partially suppressed OAG-induced transients compared to control
(Figure 6). Combined with the electrophysiology data in Figures 8
and 9, these findings suggest that MPP+ is a higher affinity
inhibitor of TRPC3 than 6-OHDA. These results are also
consistent with previous findings from our laboratory that Pyr3
was more effective at inhibiting OAG- vs. ATP-induced Ca2+
entry in astrocytes, based upon Fura-2 quenching studies [21],
consistent with the specificity of OAG for this channel subtype.
The direct effects of MPP+ and 6-OHDA on the activity of
TRPC3 channels were determined by whole-cell patch clamp
electrophysiology in primary striatal astrocytes (Figure 7). These
studies determined that OAG evoked large transient outward
currents that were partly blocked with Pyr3, suggesting the
presence of this channel in situ. Interestingly, we were unable to
record an inward current following the administration of OAG.
This may be due to non-specific PKC-dependent activation of
two-pore-domain K+ (K2P) channels [31], a major hyperpolarizing
contributor to the passive conductance of mature astrocytes [32].
OAG-sensitive activation of K+ efflux via K2P channels could
oppose any potential Na+/Ca2+ influx via TRPC3 in native cells,
yielding little or no net charge movement and could explain the
lack of inward current at hyperpolarizing potentials in our patch
clamp recordings. In contrast, ATP evoked large inward and
outward currents in astrocytes that were suppressed by both Pyr3
and MPP+ (Figure 7), suggesting that stimulation of P2Y receptors
and the PLC-dependent production of local DAG could specif-
ically activate native TRPC3-like current in astrocytes that are
disrupted by MPP+. In cells overexpressing TRPC3 (Figure 8),
electrophysiology data indicated that both inward and outward
TRPC3-dependent Ca2+ currents were blocked by MPP+ (Figur-
e 8a,b), providing evidence for direct interaction with this TRPC
channel subtype. TRPC3 currents were also partially decreased by
6-OHDA, relative to Pyr3, but to a lesser extent than MPP+,
suggesting a weaker interaction with TRPC3 for this compound.
Ca2+ responses to ATP could also implicate intracellular targets
including the ryanodine receptor (RyR). This receptor is inhibited
by toxicants such as polybrominated diphenyl ethers (PBDE’s) and
non-coplanar polychlorinated biphenyl compounds (PCB’s), which
presence of 10 mM MPP+. (c,d) Addition of 100 mM OAG induced a rapid increase in Ca2+ that was abolished by pre-incubation with Pyr3. Vertical bars
in (b and c) denote 1 relative fluorescent unit; the horizontal bars denote 10 sec. Black arrows indicate the time of stimulation with ATP or OAG.
Representative images are shown at the start of imaging (time= 0 sec) and at the application of agonist (time= 10 sec) and again at time= 60 sec.
Scale bar = 10 microns. (e,f) Luciferase (40 ng/ml) was incubated with luciferin and ATP at 22uC for 20 min in the presence of MPP+ (10 mM) 6-OHDA
(10 mM) or apyrase (5 U/ml). For imaging studies, n = 500–700 cells for each experiment over 2-3 independent experiments in separate cultures of
striatal astrocytes; for luciferase experiments, n = 4 independent replicates. *p,0.05 relative to control, ** p,0.01 relative to control and treated
groups, **** p,0.0001 compared to control, MPP+ and 6-OHDA.
doi:10.1371/journal.pone.0110996.g005
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Figure 6. MPP+ and 6-OHDA acutely inhibit OAG-induced Ca2+ transients in striatal astrocytes. (a-d) Knockdown of TRPC3 in striatal
astrocytes using siRNA decreases extracellular Ca2+ entry (secondary peak height) but not the initial ATP-induced transient (initial peak height). MPP+
only slightly enhances the inhibitory effect of TRPC3 siRNA on ATP-induced extracellular Ca2+ entry. (e) Expression of TRPC3 mRNA following 72 hrs
knockdown with siRNA oligonucleotides. Black arrows indicate the time of stimulation with 1 mM ATP. (f) Representative traces demonstrating
changes in OAG-induced Ca2+ influx following the addition of cationic neurotoxins. The vertical bar denotes 1.0 relative fluorescent unit; the
horizontal bar denotes 10 sec. Black arrows indicate the time of stimulation by 100 mM OAG. (g) Quantitative analysis of Fluo-4 fluorescence
demonstrates that OAG-induced activation of TRPC3 channels is decreased in the presence of MPP+ and 6-OHDA (10 mM each). n = 200–300 cells for
each experiment over 2–3 independent experiments in separate cultures of striatal astrocytes; *p ,0.05, **p ,0.01, ****p ,0.0001.
doi:10.1371/journal.pone.0110996.g006
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alter Ca2+ homeostasis in neural cells [33,34]. Although MPP+ is
non-coplanar [35] and could therefore potentially react with RyR,
the rapid kinetics of the inhibitory effect with MPP+ and 6-OHDA
more strongly suggest that they function as channel blockers at the
plasma membrane, as demonstrated in recent studies with the
divalent metal, Mn2+, which reversibly inhibited OAG-induced
Ca2+ transients in astrocytes by competitively decreasing Ca2+
influx through TRPC3 [21]. The electrophysiological data in the
present studies also suggests that MPP+ and, to a lesser extent 6-
OHDA, acutely decreases ATP-dependent Ca2+ transients in
astrocytes by partly by inhibiting the channel activity of TRPC3.
These data do not preclude the possibility of longer term changes
in Ca2+ signaling due to altered gene expression or translocation of
TRPC3 [36,37], but rather implicate TRPC3 as an important
acute target of these cationic neurotoxicants that can negatively
modulate Ca2+ responses of astrocytes to ATP.
Interestingly, TRPC3 is also expressed in neurons, where it is
associated with postsynaptic excitatory currents at glutamatergic
Figure 7. OAG- and ATP-induced currents in striatal astrocytes. (a) Representative time course of OAG (100 mM) -induced whole-cell currents
at +80, 0, and 280 mV and in response to TRPC3 inhibitor, pyrazole-3 (Pyr3, 10 mM) in striatal astrocytes. (b) Current (I) vs. voltage (V) relationship of
baseline and OAG-induced currents in absence and presence of Pyr3. (c) Summary data of average current density at +80 and 280 mV before and
following OAG stimulation and after administration of Pyr3. n = 5. (*p ,0.05). (c) Current (I) vs. voltage (V) relationship of baseline and ATP (1 mM) -
induced currents in striatal astrocytes in absence and presence of MPP+ (100 mM). (d) Summary data of average current density at +80 and 280 mV
before and following ATP (1 mM) stimulation and after administration of MPP+ (100 mM). n = 3. (*p ,0.05).
doi:10.1371/journal.pone.0110996.g007
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synapses. TRPC3 knockout mice display no alterations in
mobilization of Ca2+ from intracellular stores but have depreca-
tions in mGluR-mediated inward currents, indicating an impor-
tant role for TRPC3 in stimulus-dependent Ca2+ entry [38]. Our
data indicate that a similar phenomenon may be operative in
astrocytes, where inhibition of TRPC3 by MPP+ or 6-OHDA
decreases ATP-dependent Ca2+ transients partly by blocking entry
of extracellular Ca2+, thereby suppressing downstream signaling
responses to critical gliotransmitters such as ATP that are
associated with Ca2+ wave activity and intercellular communica-
tion between astrocytes (Figure 9). It is interesting to speculate that
MPP+ or 6-OHDA could also directly affect TRPC3 in neurons,
causing a general suppression of postsynaptic excitatory activity,
but addressing this question would require further investigation.
Collectively, these data indicate that ATP-induced Ca2+
signaling in striatal astrocytes is vulnerable to inhibition by
structurally distinct cationic neurotoxicants through suppression of
purinergic signaling and by inhibition of extracellular Ca2+ entry
through TRPC3. The present study therefore presents a novel
mechanism by which selected dopaminergic neurotoxins can
acutely inhibit purinerigic Ca2+ signaling in astrocytes. The
observed alterations in glial Ca2+ homeostasis could therefore
have negative effects on neuronal function in states of injury and
disease.
Figure 8. OAG-induced currents are blocked by MPP+ and 6-
OHDA in cells overexpressing TRPC3. (a) Representative time
course of OAG (100 mM) -induced whole-cell currents at +80 and
280 mV and in response to of MPP+ (100 mM) in human embryonic
kidney (HEK) cells overexpressing TRPC3-YFP. (b) Current (I) vs. voltage
(V) relationship of baseline and OAG-induced currents in absence and
presence of MPP+. (c) Summary data of average current density at +80
and 280 mV before and following OAG stimulation and after
administration of MPP+. n = 4. (*p ,0.05). (d) Representative time
course of OAG (100 mM) -induced whole-cell currents at +80 and
280 mV and in response to of 6-OHDA (100 mM) and PyR3 (10 mM). (e)
Current (I) vs. voltage (V) relationship of baseline and OAG-induced
currents recorded in absence and presence of 6-OHDA or PyR3. (f)
Summary data of average current density at +80 and 280 mV before
and following OAG stimulation and after administration of 6-OHDA or
Pyr3. n = 4. (*p ,0.05).
doi:10.1371/journal.pone.0110996.g008
Figure 9. Proposed mechanism by which cationic neurotox-
icants disrupt ATP-induced calcium signaling in astrocytes. This
scheme represents a novel pathophysiologic mechanism that calcium
signaling in astrocytes is an important target of selected dopaminergic
neurotoxicants. Adenosine triphosphate (ATP) at nanomolar to
micromolar concentrations activates metabotropic purinergic receptors
(P2Y), causing phospholipase C (PLC)-dependent release of inositol
triphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol
4,5-bisphosphate (PIP2). IP3 stimulates release of Ca
2+ from the
endoplasmic reticulum, represented by the initial peak in the trace
(blue) and DAG activates TRPC channels, allowing influx of cations,
including Ca2+, from the extracellular space, represented by the
sustained phase of the trace (red). In the presence of MPP+ or 6-OHDA,
Ca2+ influx is disrupted following stimulation with ATP or OAG, thereby
diminishing the net movement of Ca2+ into the cell.
doi:10.1371/journal.pone.0110996.g009
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Supporting Information
Figure S1 Expression of P2X/Y and TRPC receptors in
primary astrocytes. (a) Expression of ionotropic P2X receptors
in primary cortical and striatal astrocytes was determined by
reverse transcriptase-PCR (rtPCR) and indicated that all P2X
receptor subtypes are expressed in both cortical and striatal
astrocytes. (b) Metabotropic P2Y receptors were broadly expressed
in cortical astrocytes except P2Y4 and P2Y13, whereas striatal
astrocytes expressed all P2Y receptors. (c) Expression of TRPC
subfamily receptors was determined by rtPCR. TRPC receptors
1–4 were detected in primary astrocytes. Results are representative
of 2 independent experiments in separate cultures of primary
astrocytes.
(DOCX)
Table S1 Expression of P2X/Y and TRPC receptors in
primary astrocytes. (a) Expression of ionotropic P2X receptors
in primary cortical and striatal astrocytes was determined by
reverse transcriptase-PCR (rtPCR) and indicated that all P2X
receptor subtypes are expressed in both cortical and striatal
astrocytes. (b) Metabotropic P2Y receptors were broadly expressed
in cortical astrocytes except P2Y4 and P2Y13, whereas striatal
astrocytes expressed all P2Y receptors. (c) Expression of TRPC
subfamily receptors was determined by rtPCR. TRPC receptors
1–4 were detected in primary striatal astrocytes. Results are
representative of 2 independent experiments in separate cultures of
primary astrocytes.
(DOCX)
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